ACM
ADAR1 Capital Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.9M | Buy |
5,389,264
+3,902,803
| +263% | +$52.1M | 11.03% | 1 |
|
|
2025
Q1 | $15.1M | Buy |
1,486,461
+1,463,215
| +6,294% | +$14.9M | 2.81% | 7 |
|
|
2024
Q4 | $368K | Sell |
23,246
-421,822
| -95% | -$6.68M | 0.07% | 120 |
|
|
2024
Q3 | $25.8M | Sell |
445,068
-103,848
| -19% | -$6.03M | 4.2% | 8 |
|
|
2024
Q2 | $25.1M | Buy |
548,916
+210,673
| +62% | +$9.63M | 4.74% | 7 |
|
|
2024
Q1 | $22.4M | Sell |
338,243
-350,073
| -51% | -$23.2M | 5.08% | 6 |
|
|
2023
Q4 | $27.4M | Buy |
+688,316
| New | +$27.4M | 9.78% | 2 |
|